Close

Press Releases

Shilpa Launches ‘hybrid CDMO’ at DCAT

Shilpa Medicare launches its new full service ‘hybrid’ CDMO at DCAT 2025. The newly formed CDMO will see Shilpa serve both small and large molecules customers...

White Raven, a new Belgian CDMO, obtains GMP certification...

White Raven has successfully obtained GMP certification for its state-of-the-art aseptic fill & finish facility. The facility features Cytiva’s SA25 aseptic filling workcell, a...

CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction...

CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing...

Thermo Fisher to acquire Solventum’s Purification & Filtration business...

The Purification & Filtration division manufactures filters and membranes for biopharmaceutical and medical technologies, microelectronics, food and beverage goods, and drinking water. It employs over...

LINDIS Biotech Partners with Celonic for Production and Commercial...

LINDIS Biotech has received EMA Marketing Authorisation for catumaxomab, making it the only medicine licensed for the targeted and cancer-directed therapy of malignant ascites. ...

Andelyn Biosciences Expands AAV Curator Platform Offering to Include...

COLUMBUS, OH - Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has expanded its AAV Curator™ Platform...

Massilly Group to acquire the assets of Hoffmann Neopac’s...

Hoffmann Neopac has signed a sale and purchase agreement to sell the assets of its tin business to the Massilly Group that should be effective...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read